AU5025300A - Compositions for controlled release of the hormone gnrh and its analogs - Google Patents

Compositions for controlled release of the hormone gnrh and its analogs

Info

Publication number
AU5025300A
AU5025300A AU50253/00A AU5025300A AU5025300A AU 5025300 A AU5025300 A AU 5025300A AU 50253/00 A AU50253/00 A AU 50253/00A AU 5025300 A AU5025300 A AU 5025300A AU 5025300 A AU5025300 A AU 5025300A
Authority
AU
Australia
Prior art keywords
analogs
compositions
controlled release
hormone gnrh
gnrh
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU50253/00A
Inventor
Patrick J. Burns
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Southern Biosystems Inc
Original Assignee
Southern Biosystems Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Southern Biosystems Inc filed Critical Southern Biosystems Inc
Publication of AU5025300A publication Critical patent/AU5025300A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
AU50253/00A 1999-06-18 2000-05-18 Compositions for controlled release of the hormone gnrh and its analogs Abandoned AU5025300A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US33632899A 1999-06-18 1999-06-18
US09336328 1999-06-18
PCT/US2000/013615 WO2000078335A1 (en) 1999-06-18 2000-05-18 COMPOSITIONS FOR CONTROLLED RELEASE OF THE HORMONE GnRH AND ITS ANALOGS

Publications (1)

Publication Number Publication Date
AU5025300A true AU5025300A (en) 2001-01-09

Family

ID=23315592

Family Applications (1)

Application Number Title Priority Date Filing Date
AU50253/00A Abandoned AU5025300A (en) 1999-06-18 2000-05-18 Compositions for controlled release of the hormone gnrh and its analogs

Country Status (2)

Country Link
AU (1) AU5025300A (en)
WO (1) WO2000078335A1 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7833543B2 (en) 1995-06-07 2010-11-16 Durect Corporation High viscosity liquid controlled delivery system and medical or surgical device
US6413536B1 (en) * 1995-06-07 2002-07-02 Southern Biosystems, Inc. High viscosity liquid controlled delivery system and medical or surgical device
EP1274459B1 (en) * 2000-04-19 2005-11-16 Genentech, Inc. Sustained release formulations comprising growth hormone
DE10050831A1 (en) * 2000-10-05 2002-05-02 Veyx Pharma Gmbh Procedure for starting the cycle in female breeding animals
DK1372729T3 (en) 2001-02-23 2009-06-22 Genentech Inc Degradable polymers for injection
US7318931B2 (en) 2001-06-21 2008-01-15 Genentech, Inc. Sustained release formulation
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
JP4865330B2 (en) 2002-12-13 2012-02-01 デュレクト コーポレーション Oral drug delivery system
EP3025722B1 (en) 2003-10-03 2020-05-27 Thorn BioScience, LLC Process for the synchronization of ovulation for timed breeding without heat detection
AU2005287175B2 (en) 2004-09-17 2011-12-01 Durect Corporation Sustained local anesthetic composition containing preferably a sugar ester such as SAIB
US20070027105A1 (en) 2005-07-26 2007-02-01 Alza Corporation Peroxide removal from drug delivery vehicle
US8337883B2 (en) 2006-11-03 2012-12-25 Durect Corporation Transdermal delivery systems
AU2008347158B8 (en) 2007-12-06 2013-08-22 Durect Corporation Oral pharmaceutical dosage forms
US20100260844A1 (en) 2008-11-03 2010-10-14 Scicinski Jan J Oral pharmaceutical dosage forms
PL2421545T3 (en) 2009-04-23 2018-05-30 Jbs United Animal Health Ii Llc Method and composition for synchronizing time of insemination
CN113398243A (en) 2012-11-28 2021-09-17 联合动物健康第二有限责任公司 Method for synchronizing insemination times of gilts
TW201521769A (en) 2013-03-15 2015-06-16 Durect Corp Compositions with a rheological modifier to reduce dissolution variability
KR20220140711A (en) 2020-01-13 2022-10-18 듀렉트 코퍼레이션 Reduced Impurity Sustained Release Drug Delivery Systems and Related Methods

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6051558A (en) * 1997-05-28 2000-04-18 Southern Biosystems, Inc. Compositions suitable for controlled release of the hormone GnRH and its analogs

Also Published As

Publication number Publication date
WO2000078335A1 (en) 2000-12-28

Similar Documents

Publication Publication Date Title
AU5025300A (en) Compositions for controlled release of the hormone gnrh and its analogs
AU2093101A (en) Compositions for efficient release of active ingredients
AU1928501A (en) Formulations for pharmaceutical agents ionizable as free acids or free bases
AU2002233929A1 (en) Compositions of peptide crystals
HUP0203680A3 (en) Controlled release hydrocodone formulations
AU2791599A (en) Extended release dosage form
AU2002229140A1 (en) Controlled release pharmaceutical composition
HUP0204451A3 (en) Controlled release compositions comprising nimesulide
HUP0201872A3 (en) Steroid compounds and pharmaceutical compositions of the same
EP1189597A4 (en) Oil-core compositions for the sustained release of hydrophobic drugs
AU3864900A (en) Compositions and methods for their preparation from (lepidium)
AU4834900A (en) Antagonists of gonadotropin releasing hormone
IL147253A0 (en) Growth hormone formulations
AU6386801A (en) System for the release of active ingredients
HUP0201038A2 (en) Preparations for the application of anti-inflammatory agents
HK1045716A1 (en) Composition for the preservating of infectious recombinant adenoviruses
AU2773597A (en) Pharmaceutical compositions for the sustained release of insoluble active principles
AU1718301A (en) Use of sugar compositions
SG77214A1 (en) Compositions for the reduction of scarring
AU6589200A (en) Extended release formulation of etodolac
AU4742101A (en) Antagonists of gonadotropin releasing hormone
AU4738101A (en) Antagonists of gonadotropin releasing hormone
AU2829700A (en) Processes for the preparation of alpha-aminoketones
HUP0200311A3 (en) Use of aroyl- or arylalkanoylpyridazines for preparation of pharmaceutical compositions
AU2001238540A1 (en) Non-aqueous injectable formulations for extended release of somatotropin

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase